Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate Efficacy and Safety of ADVATE in the Treatment of Previously Treated Patients With Hemophilia A

NCT02170402 is registered in ClinicalTrials.gov with Baxalta now part of Shire as lead sponsor.

NCT NCT02170402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02170402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate Efficacy and Safety of ADVATE in the Treatment of Previously Treated Patients With Hemophilia A
Lead sponsor
Baxalta now part of Shire
Phase
Phase 4
Overall status
Completed
Start date
June 26, 2014
Completion date
May 31, 2016
Enrollment
82 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a